Petrovic Aleksandra, Ibric Svetlana, Trajkovic Svetlana, Popovic Radmila, Djuric Zorica, Popadic Dragica
Galenika a.d., Institute for Research and Development, Batajnicki drum b.b, Belgrade, Serbia.
Arch Pharm Res. 2009 Jul;32(7):1087-96. doi: 10.1007/s12272-009-1715-y. Epub 2009 Jul 31.
The purpose of this study was to investigate the effect of various in vitro test conditions, on the release properties of theophylline (TP) from aminophylline (AP) matrices based on different hydroxypropylmethylcellulose (HPMC) ratio and viscosity grades. The general full factorial experimental design 3 x 3 x 3 was used, based on three independent variables: applied in vitro test (X1), HPMC/drug ratio (X2) and polymer viscosity grade (X3). The drug release percent at 2h (Y(2h)), 4h (Y(4h)) and 8 h (Y(8h)) and time for 50% of TP release from matrices (Y(T50%)) were response variables. Three in vitro tests were used: test 1 and test 4 (theophylline extended-release capsules, USP 30) and half-change method. According to factorial design analyses, in vitro test was the most significant factor influencing mechanism and amount of drug release. For half change method erosion was the predominant mechanism indicating case - II transport, while for test 1 the release mechanism were followed by both diffusion and erosion. The lowest release exponent n values, obtained from Ritger-Pepass equation, for test 4 indicate diffusion process inclining from Fickian diffusion to anomalous transport. Therefore, it is in the stage of development, useful to consider the influence of various in vitro test conditions on the formulation, in order to choose an optimal test for the purpose of future drug release examination.
本研究的目的是基于不同羟丙基甲基纤维素(HPMC)比例和粘度等级,研究各种体外试验条件对氨茶碱(AP)基质中茶碱(TP)释放特性的影响。采用了3×3×3的通用全因子实验设计,基于三个自变量:应用的体外试验(X1)、HPMC/药物比例(X2)和聚合物粘度等级(X3)。2小时(Y(2h))、4小时(Y(4h))和8小时(Y(8h))时的药物释放百分比以及基质中50%TP释放的时间(Y(T50%))为响应变量。使用了三种体外试验:试验1和试验4(茶碱缓释胶囊,USP 30)以及半量变化法。根据因子设计分析,体外试验是影响药物释放机制和量的最显著因素。对于半量变化法,侵蚀是表明Ⅱ型转运的主要机制,而对于试验1,释放机制既有扩散又有侵蚀。从Ritger-Pepass方程获得的试验4的最低释放指数n值表明扩散过程从菲克扩散向非菲克转运倾斜。因此,在开发阶段,考虑各种体外试验条件对制剂的影响,以便为未来的药物释放检查选择最佳试验是有用的。